Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Ciardiello, G.
209  Ergebnisse:
Personensuche X
?
1

516P Immune response to SARS-CoV-2 vaccine in patients (pts..:

Caputo, F. ; Rotolo, M. ; Carretto, E....
Annals of Oncology.  35 (2024)  - p. S205-S206 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Description of the novel HLA‐DPB1*137:01 allele found in an..:

Cosentini, E. ; Frison, S. ; Longhi, E....
International Journal of Immunogenetics.  41 (2013)  1 - p. 92-94 , 2013
Link: https://doi.org/10.1111/..
 
?
3

Characterization of a novel HLA‐DQB1*06 allele, HLA‐DQB1*06..:

Cosentini, E. ; Andreani, M. ; Ciardiello, G...
Tissue Antigens.  82 (2013)  1 - p. 73-74 , 2013
Link: https://doi.org/10.1111/..
 
?
4

A discrepancy between serological and molecular typing resu..:

Cosentini, E. ; Frison, S. ; Longhi, E....
International Journal of Immunogenetics.  37 (2010)  4 - p. 299-300 , 2010
Link: https://doi.org/10.1111/..
 
?
5

Sequence of a novel HLA‐B*51 allele in a volunteer haematop..:

Cosentini, E. ; Longhi, E. ; Frison, S....
International Journal of Immunogenetics.  37 (2010)  5 - p. 399-400 , 2010
Link: https://doi.org/10.1111/..
 
?
6

6MO Evaluation of plasma assessed comprehensive genomic pro..:

Martini, G. ; Martinelli, E. ; Troiani, T....
Annals of Oncology.  35 (2024)  - p. S4-S5 , 2024
Link: https://doi.org/10.1016/..
 
?
7

150P Cardioimaging in stage III lung cancer patients underg..:

Gagliardi, F. ; Nardone, V. ; Grassi, R....
ESMO Open.  9 (2024)  - p. 102737 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Impact of KRASG12 mutations on survival with trifluridine/t..:

Tabernero, J. ; Taieb, J. ; Fakih, M....
ESMO Open.  9 (2024)  3 - p. 102945 , 2024
Link: https://doi.org/10.1016/..
 
?
9

35P Neutropenia and efficacy outcomes in patients with refr..:

Prager, G. ; Tabernero, J. ; Fakih, M....
Annals of Oncology.  35 (2024)  - p. S18-S19 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Immunophenotypic correlates of sustained MRD negativity in ..:

Coffey, David G. ; Maura, Francesco ; Gonzalez-Kozlova, Edgar...
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
11

PC.01.5 GUT MICROBIOTA CORRELATES WITH ANTITUMOR ACTIVITY I..:

Romeo, M. ; Iadanza, G. ; Martini, G....
Digestive and Liver Disease.  55 (2023)  - p. S79-S80 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Cetuximab as third‐line rechallenge plus either irinotecan ..:

Martini, G. ; Ciardiello, D. ; Famiglietti, V....
Cancer Medicine.  12 (2023)  8 - p. 9392-9400 , 2023
Link: https://doi.org/10.1002/..
 
?
13

Regorafenib monotherapy as second-line treatment of patient..:

Cardone, C. ; De Stefano, A. ; Rosati, G....
ESMO Open.  8 (2023)  1 - p. 100748 , 2023
Link: https://doi.org/10.1016/..
 
?
14

126P Effect of sequential antitumoral treatment with immune..:

Ciaramella, V. ; Martini, G. ; Nacca, V....
ESMO Open.  8 (2023)  1 - p. 101936 , 2023
Link: https://doi.org/10.1016/..
 
?
15

CBX2 shapes chromatin accessibility promoting AML via p38 M..:

Del Gaudio, Nunzio ; Di Costanzo, Antonella ; Liu, Ning Qing...
Molecular Cancer.  21 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
1-15